Jean-frederic Viret - Net Worth and Insider Trading
Jean-frederic Viret Net Worth
The estimated net worth of Jean-frederic Viret is at least $53,989 dollars as of 2025-07-18. Jean-frederic Viret is the CFO of Coherus Oncology Inc and owns about 61,295 shares of Coherus Oncology Inc (CHRS) stock worth over $53,989. Details can be seen in Jean-frederic Viret's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Jean-frederic Viret has not made any transactions after 2021-02-01 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Jean-frederic Viret
Jean-frederic Viret Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Jean-frederic Viret owns 2 companies in total, including Coherus Oncology Inc (CHRS) , and NGM Biopharmaceuticals Inc (NGM) .
Click here to see the complete history of Jean-frederic Viret’s form 4 insider trades.
Insider Ownership Summary of Jean-frederic Viret
| Ticker | Company | Transaction Date | Type of Owner |
|---|---|---|---|
| CHRS | Coherus Oncology Inc | 2021-02-01 | Chief Financial Officer |
| NGM | NGM Biopharmaceuticals Inc | 2023-11-03 | Chief Financial Officer |
Jean-frederic Viret Latest Holdings Summary
Jean-frederic Viret currently owns a total of 1 stock. Jean-frederic Viret owns 61,295 shares of Coherus Oncology Inc (CHRS) as of February 1, 2021, with a value of $53,989.
Latest Holdings of Jean-frederic Viret
| Ticker | Company | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CHRS | Coherus Oncology Inc | 2021-02-01 | 61,295 | 0.88 | 53,989 |
Holding Weightings of Jean-frederic Viret
Jean-frederic Viret Form 4 Trading Tracker
According to the SEC Form 4 filings, Jean-frederic Viret has made a total of 4 transactions in Coherus Oncology Inc (CHRS) over the past 5 years, including 0 buys and 4 sells. The most-recent trade in Coherus Oncology Inc is the sale of 7,402 shares on February 1, 2021, which brought Jean-frederic Viret around $159,513.
Insider Trading History of Jean-frederic Viret
- 1
Jean-frederic Viret Trading Performance
Jean-frederic Viret Ownership Network
Ownership Network List of Jean-frederic Viret
Ownership Network Relation of Jean-frederic Viret
Jean-frederic Viret Owned Company Details
What does Coherus Oncology Inc do?
Who are the key executives at Coherus Oncology Inc?
Jean-frederic Viret is the Chief Financial Officer of Coherus Oncology Inc. Other key executives at Coherus Oncology Inc include director & President and CEO Dennis M Lanfear , Chief Financial Officer Mcdavid Stilwell , and See Remarks Bryan J Mcmichael .
Coherus Oncology Inc (CHRS) Insider Trades Summary
Over the past 18 months, Jean-frederic Viret made no insider transaction in Coherus Oncology Inc (CHRS). Other recent insider transactions involving Coherus Oncology Inc (CHRS) include a net sale of 99,988 shares made by Mats Wahlstrom ,
In summary, during the past 3 months, insiders sold 99,988 shares of Coherus Oncology Inc (CHRS) in total and bought 0 shares, with a net sale of 99,988 shares. During the past 18 months, 99,988 shares of Coherus Oncology Inc (CHRS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 99,988 shares.
Coherus Oncology Inc (CHRS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Coherus Oncology Inc Insider Transactions
Jean-frederic Viret Mailing Address
Above is the net worth, insider trading, and ownership report for Jean-frederic Viret. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Jean-frederic Viret's mailing address is: South San Francisco Ca 94080.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
